Help where is needed most
We are problem solvers.
In partnership with the National Heart, Lung, and Blood Institute (NHLBI), PERSEVERE has become a reality. Why PERSEVERE? Because optimizing medical therapy saves lives in heart failure.
Our mission is to assist Heart Failure clinical care management across the entire care continuum.
PhD, Chief Executive Officer
The comprehensive PERSEVERE innovation is the outcome of 5 NHLBI SBIR Awards, speaking to its innovation excellence and clinical care adoption potential. Launched at University of California San Francisco, PERSEVERE Triage. Titrate. Refer. achieves critical Health Economics metrics. 3 are introduced below.
Efficacy. Achieve GDMT Target.
PERSEVERE successfully assists in achieving GDMT Target. For example, in the case of patients diagnosed with HFrEF.
PERSEVERE accelerates the drive to meet the cumulative GDMT 4 drug classes requirement:
RAASI dose ≥50% or ARNI @ any dose +
BB dose ≥50% + MRA @ any dose
+SGLT2i @ any dose.
Safety. Refer When Needed.
PERSEVERE assists in identifying high risk patients that require immediate referral to Advanced Heart Failure or Electrophysiology.
Clinical Utility. Improve HF Management with no additional professional resource scale-up.
PERSEVERE reduces condition-worsening through efficient management of HF patients without the need for professional resources scale-up.